GTC Biotherapeutics (fka GTCB)

[mblimon]

"I thought it was a non-answer answer".

Well, probably they have not dedicated much time to targeting this market apart from the crossing with Japanese at conferences. But the answer certainly did not sound as something which you can spin into a positive sign.

Brings me to another institutional problem. There is so much on the plate in operational and financial terms. Where do they focus?

Is having their own processing/purification plant not killing them financially ? (I know the advantages for delivering the raw materials for trials)